Fundraising FoxTransverse Medical
Denver, US · Colorado corporation
Find your way into Transverse Medical
Sign up to see every warm intro you have to Transverse Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Transverse Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
EG
Eric GoslauExecutiveEric Goslau is President and CEO of Transverse Medical, which develops the POINT-GUARD, a cerebral embolic protection device for stroke prevention during cardiovascular procedures. He brings over 30 years of medtech leadership experience in commercial sales, marketing, and product development across startups and large companies, and also serves as co-founder of Secure-Closure Inc.
Board
WG
William GoslauBoard director
TT
Ted TarasowBoard director
Reported raises · per SEC filings
Form D private placements$24.5M disclosed across 4 of 5 rounds · 2017–2024
▶$10MraisedDec 2024 · 2 investors · Other Health CareRule 506(b)
▶$10MraisedDec 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric GoslauExecutive Officer, Director
- Offering amount
- $11.2M
- Amount sold
- $10M
- First sale
- Nov 2024
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$6.6MraisedAug 2023 · 31 investors · Other Health CareRule 506(b)
▶$6.6MraisedAug 2023 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric GoslauExecutive Officer, Director
- Offering amount
- $6.6M
- Amount sold
- $6.6M
- First sale
- Aug 2023
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$140KraisedNov 2019 · 3 investors · Other Health CareRule 506(b)
▶$140KraisedNov 2019 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chad FredericksonExecutive Officer
- William GoslauDirector
- Ted TarasowDirector
- Eric GoslauExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $140K
- Minimum investment
- $25K
- First sale
- Nov 2019
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$7.8MraisedOct 2018 · 48 investors · OtherRule 506(b)
▶$7.8MraisedOct 2018 · 48 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Larry LawsonDirector
- Eric GoslauExecutive Officer, Director
- William GoslauDirector
- Ted TarasowDirector
- Chad FredericksonExecutive Officer
- Offering amount
- $9.7M
- Amount sold
- $7.8M
- Minimum investment
- $25K
- First sale
- Sep 2018
- Incorporated
- Corporation, Colorado
- Federal exemptions
- 06b
▶$3MofferedMay 2017 · OtherRule 506(b)
▶$3MofferedMay 2017 · Other
Rule 506(b)Officers, directors & promoters on the filing
- Eric GoslauExecutive Officer, Director
- William GoslauDirector
- Ted TarasowDirector
- Offering amount
- $3M
- Minimum investment
- $50K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Transverse Medical raised?
- Transverse Medical has disclosed $24.5M raised across 4 of its 5 known rounds.
- Where is Transverse Medical headquartered?
- Transverse Medical is headquartered in Denver, US.